Disc Medicine, Inc. (IRON)
57.00
+1.26
(+2.26%)
USD |
NASDAQ |
Oct 15, 10:01
Disc Medicine EPS Diluted (Quarterly) : -1.539 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.539 |
| March 31, 2026 | -1.650 |
| December 31, 2025 | -1.618 |
| September 30, 2025 | -1.772 |
| June 30, 2025 | -1.577 |
| March 31, 2025 | -1.023 |
| December 31, 2024 | -0.9863 |
| September 30, 2024 | -0.8885 |
| June 30, 2024 | -1.027 |
| March 31, 2024 | -1.086 |
| December 31, 2023 | -0.9679 |
| September 30, 2023 | -0.5808 |
| June 30, 2023 | -0.7422 |
| Date | Value |
|---|---|
| March 31, 2023 | -1.202 |
| December 31, 2022 | -1.220 |
| September 30, 2022 | -16.82 |
| June 30, 2022 | -5.505 |
| March 31, 2022 | -10.67 |
| December 31, 2021 | -19.60 |
| September 30, 2021 | -4.305 |
| June 30, 2021 | -3.821 |
| March 31, 2021 | -5.948 |
| December 31, 2020 | -9.197 |
| September 30, 2020 | -6.545 |
| June 30, 2020 | -4.437 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | -0.246 |
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -59.53M |
| Total Expenses (Quarterly) | 59.53M |
| Enterprise Value | 1.481B |
| Earnings Yield | -11.54% |
| Normalized Earnings Yield | -11.54 |